Güven puanı 8/100
Prof. Colm O'Brien
👤 16 yıllık deneyim
9,196+
Patients seen
16
Years in practice
4
Publications
1
Languages spoken
Hakkında
Professor O'Brien is a highly esteemed ophthalmologist. They are a respected clinician scientist with a substantial history of translational research in glaucoma. Professor O'Brien is passionate about mentoring trainee clinicians and scientists. Their research group focuses on the cellular mechanisms behind fibrotic pathological changes in the optic nerve and trabecular meshwork, including genetic and epigenetic alterations. The research also investigates new therapeutic interventions, such as nutritional supplementation, to enhance visual function in glaucoma.
Professor O'Brien has authored a significant number of peer-reviewed publications and has supervised numerous higher degree completions. Their contributions to the field have earned them recognition and respect within the ophthalmology community.
Professor O'Brien has authored a significant number of peer-reviewed publications and has supervised numerous higher degree completions. Their contributions to the field have earned them recognition and respect within the ophthalmology community.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Prof. Colm O'Brien
Eğitim ve öğretim
-
2000–2006 MD · Medicine and Surgery
-
2006–2010 Residency · Göz hastalıkları
Kariyer ve atamalar
-
2010-09–2011-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
IE — Medical Council of Ireland
Kurul sertifikaları
European Board of Göz hastalıkları
Mesleki sorumluluk sigortası:
AmTrust Europe · 2,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 1,662 |
| Annual physical exam | 99395 | 368 |
| Vaccination administration | 90471 | 2,296 |
| Minor procedure (skin) | 17110 | 127 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 dk | in_clinic | 540.00 EUR |
| Minor procedure (skin) | 120 dk | in_clinic | 810.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 17 · i10: 5
-
Validation of clinical scoring in Göz hastalıkları
DOI: 10.9778/euroclin.2026.0 · PMID: 32492527 · alıntılayan 46
-
Long-term follow-up of Göz hastalıkları across IE
DOI: 10.5790/euroclin.2025.1 · PMID: 30831281 · alıntılayan 132
-
Validation of clinical scoring in Göz hastalıkları
DOI: 10.5226/euroclin.2024.2 · PMID: 34662056 · alıntılayan 58
-
Long-term follow-up of Göz hastalıkları across IE
DOI: 10.7132/euroclin.2023.3 · PMID: 33145744 · alıntılayan 80
Davetli konuşmalar
- Practical updates in Göz hastalıkları European Annual Congress (Göz hastalıkları) · Vienna · 2024 · invited
- Single-centre experience in Göz hastalıkları National Society Meeting · Dublin · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Göz hastalıkları — Dublin · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2011 yılından beri
- national college of family doctors — Member · 2011 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2011 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Göz hastalıkları
- Awareness When should you see a göz hastalıkları?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · colm.obrien@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.